CoChat

Residual β-Cell Function and HLA-A24 in IDDM: Markers of Glycemic Control and Subsequent Development of Diabetic Retinopathy

Nakanishi, Koji, Kobayashi, Tetsuro, Inoko, Hidetoshi, Tsuji, Kimiyoshi, Murase, Toshio, Kosaka, Kinori · 1995 · Diabetes
Cited by 46

The DOI matches its Crossref record.

Abstract

To identify risk factors for diabetic retinopathy in insulin-dependent diabetes mellitus (IDDM), we studied the relationships among residual β-cell function, human leukocyte antigen (HLA), long-term glycemic control, and development of diabetic retinopathy in 128 IDDM patients. Residual β-cell function was assessed by serum C-peptide immunoreactivity (CPR) response to a 100-g oral glucose load (ΔCPR). The patients were stratified into three groups: those with ΔCPR of <0.033 nmol/1 (group 1, n = 50), those with ΔCPR of 0.033–0.1 nmol/1 (group 2, n = 38), and those with ΔCPR of > 0.1 nmol/1 (group 3, n = 40). The cumulative incidence rate of background retinopathy was higher in the order of groups 1, 2, and 3 (P = 0.032). Group 1 progressed to preproliferative retinopathy at an earlier stage than did groups 2 and 3 combined (P = 0.028). Further progression to proliferative retinopathy tended to be earlier in group 1 than in groups 2 and 3 combined (P = 0.083). The mean HbA1c value rose from 9.01 ± 1.06% (mean ± SD) in group 3 to 9.75 ± 0.79% in group 2 to 10.48 ± 1.12% in group 1 (P <0.0001). In group 1, 89.6% of the patients had HLA-A24, whereas 50 and 43.6% of the patients had this antigen in groups 2 and 3 respectively (P <0.0001). In Cox's proportional hazards model, both serum CPR response and mean HbA1c value were identified as independent risk factors for development of diabetic retinopathy after adjusting for other potential risk factors. These results indicate that complete loss of β-cell function, which is associated with HLA-A24, predicts earlier occurrence of diabetic retinopathy through metabolic control.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/diab.44.11.1334

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 46

Metadata

Authors
Nakanishi, K., Kobayashi, T., Inoko, H., Tsuji, K., Murase, T., & Kosaka, K.
Venue
Diabetes
Published
1995-11-01
Volume
44
Issue
11
Pages
1334-1339
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2097837124
Cited by
46
References
0
FWCI
1.56
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Residual β-Cell Function and HLA-A24 in IDDM: Markers of Glycemic Control and Subsequent Development of Diabetic Retinopathy. https://app.cochat.ai/papers/10.2337/diab.44.11.1334
The paper
Nakanishi, K., Kobayashi, T., Inoko, H., Tsuji, K., Murase, T., & Kosaka, K. (1995). Residual β-Cell Function and HLA-A24 in IDDM: Markers of Glycemic Control and Subsequent Development of Diabetic Retinopathy. Diabetes. https://doi.org/10.2337/diab.44.11.1334

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.